hesperidin has been researched along with n-methylaspartate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daigaku, R; Fujita, K; Maekawa, S; Maruyama, K; Moritoh, S; Murayama, N; Nakazawa, T; Nishiguchi, KM; Omodaka, K; Sato, K; Shiga, Y; Tawarayama, H; Yabana, T | 1 |
| Fujita, K; Ge, S; Himori, N; Maekawa, S; Nakazawa, T; Nishiguchi, KM; Ohno-Oishi, M; Omodaka, K; Ozawa, M; Sato, K; Sato, T; Shiga, Y; Yabana, T; Yasuda, M | 1 |
2 other study(ies) available for hesperidin and n-methylaspartate
| Article | Year |
|---|---|
The neuroprotective effect of hesperidin in NMDA-induced retinal injury acts by suppressing oxidative stress and excessive calpain activation.
Topics: Animals; Apoptosis; Calpain; Cells, Cultured; Disease Models, Animal; Evoked Potentials, Visual; Hesperidin; Male; Mice; N-Methylaspartate; Neuroprotective Agents; Oxidative Stress; Retina; Retinal Diseases; Retinal Ganglion Cells; Treatment Outcome; Tumor Necrosis Factor-alpha | 2017 |
CHOP deletion and anti-neuroinflammation treatment with hesperidin synergistically attenuate NMDA retinal injury in mice.
Topics: Animals; Blotting, Western; Calcium-Binding Proteins; Cytokines; Disease Models, Animal; Drug Synergism; Gene Deletion; Hesperidin; Immunohistochemistry; In Situ Nick-End Labeling; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microfilament Proteins; Microglia; N-Methylaspartate; Neuroprotection; NF-kappa B; Oxidative Stress; Real-Time Polymerase Chain Reaction; Retinal Diseases; Retinal Ganglion Cells; Transcription Factor CHOP | 2021 |